Weight loss, diabetes drugs can cause mood changes: What to know about behavioral side effects
GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on physical wellness – but what about mental health?
Some examples of these medications include semaglutides, such as Ozempic and Wegovy, and liraglutide, like Victoza and Saxenda.
Advertisement
Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression.
The National Institutes of Health (NIH) published research in June 2024 that considered the correlation between semaglutide therapy and 'exacerbating mood disturbances.'
The study highlighted the association of negative mood changes in patients with type 2 diabetes with a history of depression, warning healthcare providers to be aware of this 'potential risk.'
But a more recent study, published in the journal Diabetes, Obesity and Metabolism, suggested that these mood changes were linked to genetic variations across diverse populations and ancestries within the U.K. Biobank.
Advertisement
While GLP-1 RA variants had 'consistent cardiometabolic effects' across all groups, the researchers said the negative impacts on mental health were 'more varied,' concluding that any behavioral changes are 'likely not acting directly through [the medications].'
5 Nazario noted that GLP-1 RAs can affect mood in many different ways.
tmc_photos – stock.adobe.com
Doctors weigh in on medications and mood
Dr. Brett Osborn, a Florida neurosurgeon who often prescribes GLP-1 RAs to his patients, believes that there is 'no consistent causal relationship' between these medications and mental illness.
'Researchers assayed genetic markers across almost half a million people from different backgrounds in search of a link between the gene behind GLP-1 receptors and mental health problems like depression, anxiety or suicidal ideation — and they didn't find it,' he summarized.
Advertisement
People who are obese or battling type 2 diabetes are 'often already depressed' without the medication, the doctor pointed out.
5 Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression.
nazif – stock.adobe.com
'These conditions take a toll – physically, emotionally and socially,' he said. 'So, yes, a large portion of patients starting GLP-1 drugs are already dealing with mental health struggles. But that's not because of the drug — that's because of the disease.'
Once these individuals begin dropping weight, blood sugar stabilizes and energy improves, which usually lifts their mood as well.
Advertisement
'GLP-1 drugs help people reclaim their health,' Osborn noted. 'They reduce inflammation. They lower blood sugar. They shrink waistlines.'
5 People who are obese or battling type 2 diabetes are 'often already depressed' without the medication, the doctor pointed out.
K KStock – stock.adobe.com
'And when people look and feel better, when their bodies finally start working for them instead of against them, they often smile more, not less.'
Dr. Muhammad Ghanem, a bariatric surgeon at Orlando Health Weight Loss and Bariatric Surgery Institute, shared in a separate interview with Fox News Digital that while some of his patients have reported mood changes, others 'don't have that at all.'
'Depression or mood changes are very common regardless, especially nowadays, and so it's hard to [determine] whether this is related to the GLP-1 agonist medications, or whether it just happens to be that they started suffering from these after they started that medication,' he said.
'It's really hard to tell whether it's a personality change that can happen because of weight loss or if it's a side effect because of mood changes,' he added. 'I don't think we have enough data to reach that conclusion yet.'
Patients who lose weight with GLP-1 RAs can experience a 'big boost' in confidence, as well as a change in personality and even relationships, according to Ghanem.
5 Once these individuals begin dropping weight, blood sugar stabilizes and energy improves, which usually lifts their mood as well.
Tinnakorn – stock.adobe.com
Advertisement
'It really depends on the person and the support system they have,' he said. 'You need proper, randomized controlled trials to reach a conclusion, and better studies to determine whether this is related to the medication itself or just weight loss.'
'It's important for all doctors who prescribe these drugs to be aware and check the patient's history.'
For those who are interested in these medications or are experiencing mood changes while taking them, the surgeon stressed the importance of keeping in close contact with medical providers.
'Just like any other medication, they can have potential side effects,' he said.
Advertisement
Ghanem recommended seeking out professionals and practices who take a 'holistic approach' to weight loss, offering mental health support in addition to medication.
5 For those who are interested in these medications or are experiencing mood changes while taking them, the surgeon stressed the importance of keeping in close contact with medical providers.
alones – stock.adobe.com
Dr. Brunilda Nazario, MD, chief physician editor of medical affairs at WebMD, told Fox News Digital that 'obesity is complicated.'
'Obesity specialists … are cautiously excited about how well these drugs work,' she said.
Advertisement
'With current studies showing conflicting results on mood disorders and the use of GLP-1 drugs, it's important for all doctors who prescribe these drugs to be aware and check the patient's history before prescribing [them].'
Nazario stressed that it's 'vital' for GLP-1 RA users to listen to their bodies, urging them to pay attention to their feelings and know the symptoms of mood disorders.
'Don't be afraid to ask for help if you feel something is not right — your health depends on it,' he added.
Advertisement
Nazario noted that GLP-1 RAs can affect mood in many different ways.
'They are not all negative — they have the potential to improve mood as well,' she said. 'Just seeing great results can boost self-esteem, confidence and body image.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Ozempic sperm? Weight loss drugs can mess with fertility — for both men and women
GLP-1 drugs like Ozempic and Wegovy might help you ditch the food baby, but they could also affect your ability to make a real one. Ayla Barmmer, a registered dietitian and reproductive health expert, told The Post that about 15% of her patients using the medications have struggled to conceive. Within that group, she said roughly 40% have reported problems such as irregular periods, delayed ovulation and even declining sperm quality linked to their rapid weight loss. But in a surprising twist, some women have experienced the opposite effect on their fertility, giving rise to the so-called 'Ozempic baby.' Barmmer explained what's behind these conflicting outcomes — and shared her top recommendations for anyone taking a GLP-1 who is thinking of starting a family. GLP-1 drugs help people slim down by curbing their appetite — but that can lead to serious nutrient deficiencies if you aren't careful. 'Clinical dietitians and endocrinologists have already documented shortfalls in protein, vitamin B12, vitamin D, iron, calcium and folate among GLP‑1 users, especially once weight loss exceeds 10% of baseline,' Barmmer said. Those missing nutrients are key players in egg and sperm development, hormone production and embryo health. To make matters worse, sudden weight loss or undereating triggers the brain's alarm system. As a result, the hypothalamus pumps the brakes on reproductive hormone production to save energy. 'Women tend to experience cycle changes first, whereas men more often present with falling testosterone, lower semen volume and reduced motility after significant weight loss,' Barmmer said. For women, this can also cause luteal-phase defects, where the uterine lining doesn't thicken enough to support pregnancy. But it's not all bad news for baby-making. GLP-1s have sparked a flood of social media posts from women stunned to find themselves pregnant just months after starting the drugs — including those who were once told they couldn't conceive. Barmmer said the fertility boost likely comes from the drugs' ability to improve insulin sensitivity and reduce systemic inflammation. Take polycystic ovary syndrome, a top cause of infertility in women that often leads to irregular or missing periods. 'For those with PCOS, which is the No. 1 endocrine disorder worldwide, GLP-1s have been shown to restore ovulation due primarily to the positive impact on insulin sensitivity,' she explained. Barmmer also noted GLP-1 receptors have been found in the lining of the uterus, ovaries and testes — where they may fight inflammation and the buildup of fibrous tissue that harms fertility. That could help ovarian follicles thrive and embryos implant. It might even boost sperm quality, improving concentration and motility. 'There is this delicate line where there are benefits for fertility as long as nutritional needs are met,' Barmmer said. If you're on a GLP-1 and hope to grow your family one day, you probably don't need to quit the drugs cold turkey. 'Much of the risk is attributed to not paying careful attention to meeting nutrient needs while losing weight, which can be mitigated,' Barmmer said. Some of her patients have continued using the medication while her team adjusts their diet and monitors nutrient levels through regular lab work. Others have chosen to taper off eight to 10 weeks before trying to conceive, giving the drug time to clear their system. 'The worst case scenario is to start trying to conceive with depleted in key nutrients that impact conception, the health of the pregnancy and even the baby's long-term health,' Barmmer warned. 'This goes for both women and men because men's preconception nutrition status has a profound impact on the risk for pregnancy complications,' she added. To support fertility while on a GLP-1, Barmmer recommends consuming at least 1.4 grams of protein per kilogram of your target body weight each day. You should also include a source of healthy fat in every meal and keep your calorie intake above 30 kilocalories per kilogram to prevent your reproductive system from slowing down. Barmmer encourages her patients to focus on foods rich in protein, iron, choline, omega‑3 fatty acids, zinc, selenium and antioxidants. She recommends getting lab work every three months to make sure nutritional needs are being met. 'This is a vital time to work with a registered dietitian, particularly one who is also a fertility expert,' she said. And no, standard prenatal vitamins aren't enough on their own. While helpful, Barmmer said they don't deliver the extra protein, omega‑3 fats or calories needed for reproductive cell development and early embryo growth. They also can't fix common gastrointestinal side effects associated with GLP-1s — like nausea, early satiety or malabsorption — that can limit nutrient uptake. Even still, 'a very nutrient-dense, comprehensive and thoroughly tested prenatal multivitamin and omega-3 fatty acid supplement are absolutely necessary,' Barmmer said. If pregnancy is on your immediate to-do list, she recommends stopping GLP-1s at least eight weeks before trying to conceive to allow your ovulation or semen quality to return to normal. If your period has been missing or your nutrition is off-track, it might take longer. Bottom line: You don't necessarily have to break up with your weight-loss medications to start a family — but you do need a game plan. 'When GLP‑1 therapy is combined with intentional, nutrient‑dense eating, the right supplement protocol and careful monitoring,' Barmmer said, 'many clients move from 'weight‑management mode' to 'family‑building mode' with healthy, predictable cycles and robust semen quality.' 'The key is giving the body both the biochemical signals and the raw materials it needs to support optimal reproductive health,' she added.
New York Post
4 hours ago
- New York Post
Ozempic users are hooked on this popular drink — which was just ranked the unhealthiest bottled beverage in the US right now
They're pumping protein — and guzzling sugar bombs. Fairlife's Core Power protein shakes — beloved by fitness fanatics and Ozempic users alike — have just been crowned the unhealthiest bottled beverage in America, despite their muscle-boosting reputation, according to Eat This, Not That! Shakes like these are a 'great way to start the day without having to sit down and have a full breakfast,' gushed Elise Ramer, a 42-year-old PR pro in Florida, previously reported on by The Post. Advertisement Ramer said she puts Core Power in her coffee while taking the weight-loss drug Mounjaro — since users need to focus on their protein intake due to the possible muscle loss side effect. But nutrition experts are throwing a red flag on the play. 'I put these first [as the unhealthiest bottled drink in the U.S.] because they are so highly marketed as a great source of protein and a healthy food when in reality they are a disaster to your metabolic health,' registered dietitian Mary Sabat recently told Eat This, Not That! Advertisement 3 Experts warn that protein shakes — a hit with many Ozempic users (above) — are hyped as health drinks but are actually a metabolic meltdown in a bottle. myskin – 'Core Power protein shakes may seem like a convenient post-workout drink, but a closer look at the ingredients reveals several health concerns.' The shakes are made by Fairlife, owned by Coca-Cola, and boast up to 42 grams of protein per bottle — but that muscle comes with a side of controversy. According to Sabat, it's not just about sugar. 'They use non-organic, conventional dairy, which often comes from cows fed GMO corn and soy and may contain residues of hormones and antibiotics — unlike grass-fed dairy, which is higher in omega-3s and CLA and free from harmful residues,' she told the outlet. Advertisement 'The addition of carrageenan, a thickening agent linked to gut inflammation and irritation, further detracts from its health profile.' Sabat also slammed the inclusion of artificial sweeteners like sucralose and acesulfame potassium, warning they've been 'associated with gut microbiome disruption and potential carcinogenic effects in animal studies.' 3 The shakes, churned out by Coca-Cola-owned Fairlife, pack a whopping 42 grams of protein — but that muscle boost comes with a side of scandal. And it's not just sugar, warns Sabat. Jammy Jean – She added, 'Lastly, the label includes 'natural flavors,' a term that can encompass up to 100 different undisclosed chemical additives, many of which are far from natural. Together, these ingredients make Core Power far less healthy than its marketing implies.' Advertisement That hasn't stopped the protein craze. Thanks to the Ozempic effect, these shakes are flying off shelves faster than a gym bro's tank top. Sales of protein and meal-replacement drinks surged 11.1% to a whopping $4.7 billion last year — and it's the Ozempic army leading the charge, retail tracker SPINS revealed. As The Post previously reported, Rila Global Consulting found 13% of those on GLP-1 drugs like Ozempic and Mounjaro had consumed protein shakes in the past two years. But some experts warn that overloading on protein — especially the highly processed kind — can backfire. 3 As The Post previously reported, 13% of Ozempic and Mounjaro users have chugged protein shakes in the past two years, according to Rila Global Consulting. Tobias Arhelger – Dr. Joseph Antoun, CEO of longevity company L-Nutra, previously told The Post that too much animal protein can raise IGF-1 levels, a hormone linked to accelerated aging, cancer and diabetes. 'The goal isn't to just build muscle — it's to live long enough to use it,' he said. In the meantime, maybe stick to a protein-packed egg — and leave the mystery 'natural flavors' to the lab rats.
Yahoo
6 hours ago
- Yahoo
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench space than other products in its class.2 Takes the industry-leading sensitivity of Xevo TQ Absolute to new heights, including for PFAS detection and pharma quantitation applications. BALTIMORE and MILFORD, Mass., June 4, 2025 /PRNewswire/ -- 73rd ASMS Conference on Mass Spectrometry and Allied Topics – Waters Corporation (NYSE:WAT) today announced the launch of the Xevo™ TQ Absolute XR Mass Spectrometer, the Company's most sensitive, robust, and reliable benchtop tandem quadrupole. Notably, the product exceeds the performance capabilities of the Xevo TQ Absolute, which itself set the benchmark in the industry for tandem quadrupole sensitivity, particularly in areas such as pharmaceutical quantitation and PFAS detection. Tailored for high-throughput applications in pharmaceutical companies, contract testing organizations, and government laboratories, the new system is designed to deliver exceptional performance for the most sensitive trace-level analyses in complex matrices, while maximizing system uptime and efficiency. "Analytical laboratories are under pressure to adapt to the complex needs of pharmaceutical organizations, and meet the increasing demand for PFAS testing driven by a rapidly evolving regulatory landscape," said James Hallam, Vice President, Liquid Chromatography-Mass Spectrometry, Waters Corporation. "The Xevo TQ Absolute XR design delivers up to a six-fold increase in performance robustness with unmatched sensitivity and resilience to contamination, significantly reducing downtime and enhancing operational efficiency for our customers." Built on the trusted, intuitive design of the Xevo TQ Absolute Mass Spectrometer, the Xevo TQ Absolute XR Mass Spectrometer offers significant operational efficiencies. It uses up to 50% less power and nitrogen gas, produces 50% less heat than any other high-performing tandem or triple quadrupole on the market, and takes up to 50% less bench space, making it the ideal system for laboratories striving to reduce their environmental footprint without compromising throughput or performance. Within the Xevo TQ Absolute XR Mass Spectrometer, Waters introduces the StepWave XR Ion Guide, which incorporates sophisticated technology designed to minimize the risk of unplanned downtime, while preserving high sensitivity and precision for even the most complex sample types and fragile compounds. Through this innovation, customers are realizing a new benchmark of robustness across a wide range of applications, including PFAS, bioanalysis, and genotoxic impurity testing. "Our laboratory requires instrumentation that delivers high-quality, interruption-free results to our customers, helping them to bring safe and effective new drugs to market with confidence and speed," said Sally Hannam, Scientific Director, Synexa Life Sciences, a leading biomarker and bioanalytical services provider. "We are well in excess of 20,000 injections of crashed human plasma continuously analyzed on the Xevo TQ Absolute XR Mass Spectrometer combined with the ACQUITY™ Premier UPLC™ System and waters_connect™ Software, and our early experience is that it demonstrates new levels of reproducibility and accuracy, giving us ever more confidence as we are presented with increasingly challenging bioanalysis applications and new modalities." In addition, the design of the Xevo TQ Absolute XR Mass Spectrometer delivers industry-leading, out-of-the-box quantitation of negatively ionizing compounds, such as PFAS. Bioanalytical, food safety, and environmental testing laboratories will benefit from the high confidence results and operational efficiency gains that the Xevo TQ Absolute XR Mass Spectrometer delivers. The Xevo TQ Absolute XR Mass Spectrometer is available to order now. Additional Resources Product Page Waters, StepWave, ACQUITY, UPLC, waters_connect, and Xevo are trademarks of Waters Technologies Corporation. ABOUT: Waters Corporation (NYSE:WAT) is a global leader in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences for over 65 years. Our Company helps ensure the efficacy of medicines, the safety of food and the purity of water, and the quality and sustainability of products used every day. In over 100 countries, our 7,600+ passionate employees collaborate with customers in laboratories, manufacturing sites, and hospitals to accelerate the benefits of pioneering science. Contact: Molly GluckHead of External CommunicationsWaters Corporationmolly_gluck@ +1.617.833.8166 Application Note on Product Webpage. In a well-controlled experiment, performance was maintained for up to six times the duration on the Xevo TQ Absolute XR compared to the Xevo TQ Absolute; more than 12,000 samples of pesticides in fish feed matrix were analyzed. Based on a comparison of high-end tandem and triple quadrupole instruments available on the market. [Infographic] View original content: SOURCE Waters Corporation Sign in to access your portfolio
